Effect of LY333328 against vancomycin-resistant Enterococcus faecium in a rat central venous catheter-associated infection model

Research output: Contribution to journalArticle

45 Scopus citations

Abstract

A rat central venous catheter (CVC) infection model was used to assess the activity of LY333328 against vancomycin-resistant Enterococcus faecium (VRE). Via the CVC, animals were challenged with 106 cfu of Enterococcus faecium with the VanA phenotype. Eight rats received a single dose of LY333328 and eight rats received saline. Seventy-five per cent of control animals had peripheral bacteraemia and 87.5% had VRE recovered from explanted CVCs at the time they were killed, as compared with 0 and 12.5%, respectively, of the LY333328-treated animals (P < 0.01). All animals in the control group had evidence of metastatic disease compared with none of the treated group (P < 0.01). LY333328 was effective against the strain of VRE tested in this model.

Original languageEnglish (US)
Pages (from-to)705-707
Number of pages3
JournalJournal of Antimicrobial Chemotherapy
Volume47
Issue number5
DOIs
StatePublished - 2001

ASJC Scopus subject areas

  • Pharmacology
  • Microbiology (medical)
  • Infectious Diseases
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Effect of LY333328 against vancomycin-resistant Enterococcus faecium in a rat central venous catheter-associated infection model'. Together they form a unique fingerprint.

  • Cite this